Company profile for Faeth Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Faeth Therapeutics, headquartered in San Francisco, was founded to translate breakthrough discoveries, made by world-leading cancer research laboratories into clinical practice. The company is converging precision therapeutics, software and nutrition to treat cancer. Precise nutritional interventions are delivered to the patient at home, with AI-guided software to provide a seamless experience and access to dieticians to deliv...
Faeth Therapeutics, headquartered in San Francisco, was founded to translate breakthrough discoveries, made by world-leading cancer research laboratories into clinical practice. The company is converging precision therapeutics, software and nutrition to treat cancer. Precise nutritional interventions are delivered to the patient at home, with AI-guided software to provide a seamless experience and access to dieticians to deliver the greatest treatment outcomes possible.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
San Francisco, CA
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251020873374/en/CORRECTING-and-REPLACING-Faeth-Therapeutics-%2492-Million-Total-Funding-Powers-PIKTOR-Phase-2-Following-80-Response-Rate-in-Endometrial-Cancer

BUSINESS WIRE
27 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-20/faeth-therapeutics-92-million-total-funding-powers-piktor-phase-2-following-80-response-rate-in-e

PHARMIWEB
20 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-19/esmo-2025-faeth-therapeutics-phase-2-dice-trial-shows-34-reduction-in-risk-of-disease-progression

PHARMIWEB
19 Oct 2025

https://www.businesswire.com/news/home/20250930431334/en/Faeth-Therapeutics-RD-Platform-Delivers-First-Cross-Disease-Validation-Beyond-Oncology

BUSINESSWIRE
30 Sep 2025

https://www.businesswire.com/news/home/20250924596892/en/Faeth-Therapeutics-Announces-Late-Breaking-Presentation-of-Positive-Phase-2-Data-in-Ovarian-Cancer-at-ESMO-2025

BUSINESSWIRE
24 Sep 2025

https://www.businesswire.com/news/home/20250513965407/en/Faeth-Therapeutics-Shows-Preclinical-Proof-of-Concept-for-Drug-Diet-Combination-to-Treat-Cancer-in-Peer-Reviewed-Publication

BUSINESSWIRE
13 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty